Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features
- PMID: 15117846
- DOI: 10.1161/01.CIR.0000126826.58526.14
Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features
Abstract
Background: Although most randomized clinical trials have suggested that long-term survival rates after percutaneous coronary intervention (PCI) or surgical multivessel coronary revascularization (CABG) are equivalent, some post hoc analyses in high-risk groups and adjustment for severity of coronary disease have suggested higher mortality after PCI.
Methods and results: We studied 6033 consecutive patients who underwent revascularization in the late 1990s. PCI was performed in 872 patients; 5161 underwent CABG. Half the patients had significant left ventricular dysfunction or diabetes. Propensity analysis to predict the probability of undergoing PCI according to 22 variables and their interactions was used. The C-statistic for this model was 0.90, indicating excellent discrimination between treatments. There were 931 deaths during 5 years of follow-up. The 1- and 5-year unadjusted mortality rates were 5% and 16% for PCI and 4% and 14% for CABG (unadjusted hazard ratio, 1.13; 95% CI, 1.0 to 1.4; P=0.07). PCI was associated with an increased risk of death (propensity-adjusted hazard ratio, 2.3; 95% CI, 1.9 to 2.9; P<0.0001). This difference was observed across all categories of propensity for PCI and in patients with diabetes or left ventricular dysfunction. Other independent predictors of mortality (P< or =0.01 for all) were renal dysfunction, age, diabetes mellitus, chronic lung disease, peripheral vascular disease, left main trunk stenosis, and extent of coronary disease (Duke angiographic score).
Conclusions: In patients with multivessel coronary artery disease and many high-risk characteristics, CABG was associated with better survival than PCI after adjustment for risk profile.
Comment in
-
Surgery may be better than PCI in patients with multivessel disease at high risk.Circulation. 2004 May 18;109(19):e9043-4. doi: 10.1161/01.CIR.0000133005.91952.C4. Circulation. 2004. PMID: 15148285 No abstract available.
Similar articles
-
Comparing long-term survival of patients with multivessel coronary disease after CABG or PCI: analysis of BARI-like patients in northern New England.Circulation. 2005 Aug 30;112(9 Suppl):I371-6. doi: 10.1161/CIRCULATIONAHA.104.526392. Circulation. 2005. PMID: 16159849 Clinical Trial.
-
Survival in patients with peripheral vascular disease after percutaneous coronary intervention and coronary artery bypass graft surgery.Ann Thorac Surg. 2004 Aug;78(2):466-70; discussion 470. doi: 10.1016/j.athoracsur.2004.01.044. Ann Thorac Surg. 2004. PMID: 15276497 Review.
-
Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS).Am Heart J. 2005 Mar;149(3):512-9. doi: 10.1016/j.ahj.2004.10.010. Am Heart J. 2005. PMID: 15864241 Clinical Trial.
-
Long-term outcomes of coronary-artery bypass graft surgery versus percutaneous coronary intervention for multivessel coronary artery disease in the bare-metal stent era.Circulation. 2008 Sep 30;118(14 Suppl):S199-209. doi: 10.1161/CIRCULATIONAHA.107.735902. Circulation. 2008. PMID: 18824755
-
Survival after coronary revascularization among patients with kidney disease.Circulation. 2004 Oct 5;110(14):1890-5. doi: 10.1161/01.CIR.0000143629.55725.D9. Epub 2004 Sep 27. Circulation. 2004. PMID: 15451786 Review.
Cited by
-
Contemporary Coronary Artery Bypass Grafting vs Multivessel Percutaneous Coronary Intervention.Ann Thorac Surg. 2023 Dec;116(6):1213-1220. doi: 10.1016/j.athoracsur.2023.05.032. Epub 2023 Jun 22. Ann Thorac Surg. 2023. PMID: 37353103
-
Comparison of Coronary Artery Bypass Grafting and Drug-Eluting Stent Implantation in Patients With Chronic Kidney Disease: A Propensity Score Matching Study.Front Cardiovasc Med. 2022 Apr 1;9:802181. doi: 10.3389/fcvm.2022.802181. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35433853 Free PMC article.
-
The CHA2DS2-VASc Score as an Early Predictor of Graft Failure After Coronary Artery Bypass Surgery.Cureus. 2022 Mar 4;14(3):e22833. doi: 10.7759/cureus.22833. eCollection 2022 Mar. Cureus. 2022. PMID: 35382183 Free PMC article.
-
Short Term Prognosis of Renal Artery Stenosis Secondary to Acute Type B Aortic Dissection With TEVAR.Front Cardiovasc Med. 2021 Apr 23;8:658952. doi: 10.3389/fcvm.2021.658952. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 33969023 Free PMC article.
-
Hybrid myocardial revascularization.Indian J Thorac Cardiovasc Surg. 2018 Dec;34(Suppl 3):310-320. doi: 10.1007/s12055-018-0646-y. Epub 2018 Mar 5. Indian J Thorac Cardiovasc Surg. 2018. PMID: 33060954 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
